ASA
AGN

Armstrong Shaw Associates’s Allergan plc AGN Stock Holding History

Armstrong Shaw Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,409
Closed -$1.26M – 41
2018
Q4 		$1.26M Sell
9,409
-257
-3% -$42.1K 1.31% 26
2018
Q3 		$1.84M Sell
9,666
-145
-1% -$26.6K 1.58% 25
2018
Q2 		$1.64M Sell
9,811
-1,817
-16% -$292K 1.48% 27
2018
Q1 		$1.96M Buy
11,628
+201
+2% +$33.7K 1.77% 26
2017
Q4 		$1.87M Sell
11,427
-454
-4% -$81.5K 1.58% 28
2017
Q3 		$2.44M Sell
11,881
-16,637
-58% -$3.87M 2.2% 25
2017
Q2 		$6.93M Sell
28,518
-15,914
-36% -$3.74M 2.61% 23
2017
Q1 		$10.6M Sell
44,432
-2,716
-6% -$632K 2.65% 22
2016
Q4 		$9.9M Sell
47,148
-2,938
-6% -$609K 2.35% 25
2016
Q3 		$11.5M Buy
+50,086
New +$12.2M 2.87% 20

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Armstrong Shaw Associates's AGN Position: Q1 2019 in Review

Armstrong Shaw Associates sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 9,409 shares — an estimated $1.26M sold.

Armstrong Shaw Associates first reported a position in AGN in Q3 2016 and held it in 10 quarters. The position peaked at $11.5M in Q3 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Armstrong Shaw Associates reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Armstrong Shaw Associates sold 9,409 Allergan plc shares in Q1 2019, an estimated $1.26M.
  • Armstrong Shaw Associates first reported a position in Allergan plc in Q3 2016 and held it in 10 quarters.
  • Armstrong Shaw Associates's Allergan plc position peaked at $11.5M in Q3 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Armstrong Shaw Associates's 13F filing for Q1 2019, filed 8 May 2019.